17
8/9/11 1 GlutamateinOCD: AnUpdate ChristopherPi<enger MD,Ph.D. YaleOCDResearchClinic NewHaven,CT Disclosures  O-labelusesofs everalmedicaons (riluzole,meman ne, N-acetylcysteine, topiramate,lamotrigi ne,ketamine)wil l bediscussed  Noindustrysponsorshipofthiswork  Dr .Pi<engerisaconsult anttoRochePharmaceucalsand receivesin-kindr esearchsupportfromPz er . Overview  Introducon  Neurotransmi<ersinOCD  Genecs  Neurochemistry  Treatmentstudies  Outstandingissues  Conclusion TheburdenofOCD  2-2.5%prevalenceworldwide  Under-diagnosedandunder-treated  Hugeburdenof disease-project edtobeamong the20leadingc auseofdisabili ty(indisability - adjustedlif eyearslo st),amongall medicaland psychiatri ccondions,ind evelopedcountri esby 2020.  Highestrateof‘severe’illnessofanyanxiety disorder(51%;ECAstudy)

Glutamate in OCD an Update

Embed Size (px)

Citation preview

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 1/17

8/9/11

1

GlutamateinOCD:

AnUpdateChristopherPi<enger

MD,Ph.D.

YaleOCDResearchClinic

NewHaven,CT

Disclosures

•  Off-labelusesofseveralmedicaons(riluzole,memanne,

N-acetylcysteine,topiramate,lamotrigine,ketamine)will

bediscussed

•  Noindustrysponsorshipofthiswork

•  Dr.Pi<engerisaconsultanttoRochePharmaceucalsand

receivesin-kindresearchsupportfromPfizer.

Overview

•  Introducon•  Neurotransmi<ersinOCD

•  Genecs•  Neurochemistry

•  Treatmentstudies

•  Outstandingissues

•  Conclusion

TheburdenofOCD

•  2-2.5%prevalenceworldwide

•  Under-diagnosedandunder-treated

•  Hugeburdenofdisease-projectedtobeamong

the20leadingcauseofdisability(indisability-

adjustedlifeyearslost),amongallmedicaland

psychiatriccondions,indevelopedcountriesby

2020.

•  Highestrateof‘severe’illnessofanyanxietydisorder(51%;ECAstudy)

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 2/17

8/9/11

2

Currenttreatmentsandtheir

limitaons

•  Cognive-behavioraltherapy(CBT)

Currenttreatmentsandtheir

limitaons

•  Cognive-behavioraltherapy(CBT)•  Pharmacotherapy

 – SSRIsandclomipramine

 – Augmentaonwithatypicalanpsychocs

 – Lesswellestablishedaugmentaonstrategies

Currenttreatmentsandtheir

limitaons

•  Cognive-behavioraltherapy(CBT)•  Pharmacotherapy

 – SSRIsandclomipramine

 – Augmentaonwithatypicalanpsychocs

 – Lesswellestablishedaugmentaonstrategies

•  Invasivetreatmentopons – Neurosurgicallesions

 – Deepbrainsmulaon

NEUROTRANSMITTERS

INOCD

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 3/17

8/9/11

3

Establisheddrugtargets:

serotoninanddopamine

dopamine

serotonin

Noveldrugtargets-glutamate

glutamate

OCD-neurocircuitry

Hansenetal,2002

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 4/17

8/9/11

4

GlutamateinOCD:

thetake-home

•  ThereisincreasinglygoodconvergentevidencethatglutamateisdysregulatedinOCD

•  However,lifeisnotsosimple,andthereismuchwedonotyetknow:

 – How?Up,down,orsideways?

 – Where?

 – Why?Causeoreffect?

 – Whocares?Quesonofclinicalrelevance

GENETICS

SLC1A1

Dickeletal,2006

Arnoldetal,2006

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 5/17

8/9/11

5

Slc1A1–confirmatory

studies

•  Stewartetal,2007

•  Liangetal,2008–potenalrelaonshipbetweenSlc1A1andlocusonchromosome14

incompulsivehoarding

•  Shugartetal,2009•  Wendlandetal,2009–Slc1A1variantsaffect

expressioninlymphoidssueandinbrain

Wedlandetal,2009

Slc1A1variantscanaffect

expressioninbrain

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 6/17

8/9/11

6

SAPAP3knockoutproduces

OCD-likebehaviors

Welchetal,2007

SAPAP3knockoutproduces

OCD-likebehaviors

Welchetal,2007

DoesSAPAP3contributeto

OCDinpaents?•  Bienvenuetal,2008–noassociaonofSAPAP3withOCD,butmaycontributeto

trichollomaniaandothergroomingdisorders

•  Züchneretal,2009–maybe.Morerare

mutaonsinpaentswithOCDthanin

controls

NEUROCHEMISTRY

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 7/17

8/9/11

7

Evidencefordisruptedglutamate

regulaoninOCD-CSF

Chakrabartyetal,2005OCD CONTROL

Evidencefordisruptedglutamate

regulaoninOCD-CSF

Bha<acharyyaetal,2009

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 8/17

8/9/11

8

Evidencefordisruptedglutamate

regulaoninOCD-MRS

Rosenbergetal,2000

Evidencefordisruptedglutamate

regulaoninOCD-MRS

Rosenbergetal,2000

Rosenbergetal,2004

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 9/17

8/9/11

9

Rosenbergetal,2000

Evidencefordisruptedglutamate

regulaoninOCD-MRS

Rosenbergetal,2000

Evidencefordisruptedglutamate

regulaoninOCD-MRS

Pi<engeretal,unpublished Pi<engeretal,unpublished

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 10/17

8/9/11

10

Pi<engeretal,unpublished

STRUCTURE STUDY RESULT NOTES

Caudate Rosenberg2000 Glx Pediatric

Bartha1996 Glx Adult

Starck2008 Glx Adult

Wh ite side 2006 G lx Adult.Glx

correlatedwithY-

BOCS

Anterior

cingulate

Rosenberg2004 G lx Pediatric

Starck2008 Glx Adult

Yucel2008 Glx Adult;Glx

correlatedwithY-

BOCSinwomen

Pi<enger,

unpublished

GLU Adult;effectseen

onlyinnon-

depressed

paents

TREATMENTSTUDIES

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 11/17

8/9/11

11

Open-labelstudyofriluzole

Coricetal,2005

Open-labelstudyofriluzole

Coricetal,2005

Follow-upopen-labelstudy

Pi<engeretal,2008

RiluzoleinPediatricOCDPaents

(Grantetal,unpublisheddata)

•  Openlabel,12wktrialofriluzoleatNIMH

•  Sixpaents,ages8-16

•  CY-BOCSimprovedby38%fortheenregroupofpaents

 –  4outof6paentswithclinicallymeaningfulimprovement

 –  2outof6paentswithli<leornochange

•  Double-blindplacebocontrolledtrialunderway

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 12/17

8/9/11

12

Riluzolebenefitsanxietyand

depression

Pi<engeretal,2008

MemanneinOCD

Aboujaouedetal,200914paentswithtreatment-refractoryOCD

6respondedtomemanneaugmentaon

Respondershadlessseverediseasethannon-responders

Feusneretal,200910paentswithOCD&7withGAD

Bothgroupsimproved;OCDgroupimprovedmore(40%)

Stewartetal,2010OCDIinpaents;22receivedmemanneand22didnot

Memannegroupimprovedmore

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 13/17

8/9/11

13

KetamineinOCD?

Rodriguezetal,2011

AdjuncveglycineinOCD?

Greenbergetal,2009

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 14/17

8/9/11

14

AdjuncvesarcosineinOCD?

Wuetal,2011

N-acetylcysteine

OUTSTANDINGISSUES

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 15/17

8/9/11

15

1.Up,down,orsideways?

•  Slc1A1geneclinkagesuggestsexcessiveextracellularglutamate–IFwearerightin

assumingthatthemutantgeneishypofunconal

•  IncreasedCSFglutamatesuggestsaglobalexcess

BUT......

1.Up,down,orsideways?

•  MRSmeasurementsareinconsistent–upor

unchangedincaudate,downorunchangedin

anteriorcingulate

•  Both‘an-glutamate’and‘pro-glutamate’

medicaonshaveshownpromise,mostlyin

uncontrolledstudies

2.Whereistheabnormality?

•  MRSstudiessuggestdifferentabnormaliesin

differentbrainregions

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 16/17

8/9/11

16

2.Whereistheabnormality?

•  MRSstudiessuggestdifferentabnormaliesin

differentbrainregions

3.Who?

•  Slc1A1,andotherglutamate-relatedgenes,

areabnormalonlyinaminorityofpaents

•  BothCSFandMRSmeasurementsshow

substanaloverlapbetweenpaentand

controlgroups

OC

D

CONTR

OL

3.Who? 4.Why?Causeoreffect?

•  Glutamateelevaonmaysimplyreflectneural

hyperacvity

8/3/2019 Glutamate in OCD an Update

http://slidepdf.com/reader/full/glutamate-in-ocd-an-update 17/17

8/9/11

17

5.Dowecare?

•  Uncontrolledtrialsofglutamate-modulang

medicaonsshowpromise–especially

riluzole,memanne,andperhapscarnine

•  Nodefinive,well-controlledtrialshavebeen

describedtodate.Placebo-controlledtrialsof

riluzoleareunderway.

MichaelBloch,MD,MS

SuzanneWasylink,RNC

EileenBillingslea,MS

VladCoric,MD

KyleWilliams,MD

LisaSander,BA•BenKelmendi,MD

KaitlynPanza,BA•SeanPalermo,BA

AngeliLanderos-Weisenberger,MD

EwgeniJabukovski,BA

Acknowledgements

GerardSanacora,MD,Ph.D.

JohnKrystal,MD

ZubinBhagwagar,MD,Ph.D.

RobertMalison,MD

GraemeMason,Ph.D.

MouniraBanasr,Ph.D.

Chiang-ShanRayLi,MD

Acknowledgements

NIMH(K08MH081190;R34MH083115)

YaleCenterforClinicalInvesgaon

DorisDukeCharitableFoundaon

Obsessive-CompulsiveFoundaon

OURPATIENTSANDTHEIRFAMILIES

Acknowledgements